Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
102.61
-8.39 (-7.56%)
Nov 20, 2025, 4:00 PM EST - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $109.83 million as of November 21, 2025. Its market cap has increased by 392.35% in one year.
Market Cap
109.83M
Enterprise Value
100.51M
1-Year Change
392.35%
Ranking
Category
Stock Price
$102.61
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $109.83M, a decrease of -70.98%. That is a compound annual growth rate of -21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 109.83M | 533.13% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.11% |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 930.98B |
| Johnson & Johnson | 488.48B |
| AbbVie | 404.94B |
| UnitedHealth Group | 283.65B |
| AstraZeneca | 277.11B |
| Novartis AG | 243.58B |
| Merck & Co. | 234.40B |
| Abbott Laboratories | 215.92B |